Revvity, Inc. (RVTY) stock
RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29
Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3042% above fair value
$147.79−1.06 (-0.71%)
Close on Nov 17, 2026Market cap $16.49BP/E 70.4Yield 0.19%
Revvity r&d expenses
Research and development expenses are spending on new products and technology.
Revvity's R&D Expenses for the twelve months ending Jul 5, 2026 was $215.83M, up 5.2% year over year. For fiscal 2025 it was $215.84M, up 9.7% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $221.62M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $215.84M | +9.7% |
| FY2024 | Dec 29, 2024 | $196.84M | -9.1% |
| FY2023 | Dec 31, 2023 | $216.58M | -2.3% |
| FY2022 | Jan 1, 2023 | $221.62M | +10.6% |
| FY2021 | Jan 2, 2022 | $200.34M | +36.8% |
| FY2020 | Jan 3, 2021 | $146.44M | -22.7% |
| FY2019 | Dec 29, 2019 | $189.34M | -2.4% |
| FY2018 | Dec 30, 2018 | $194.00M | +39.1% |
| FY2017 | Dec 31, 2017 | $139.46M | +12.3% |
| FY2016 | Jan 1, 2017 | $124.18M | +10.3% |
| FY2015 | Jan 3, 2016 | $112.54M | +4.1% |
| FY2014 | Dec 28, 2014 | $108.06M | -18.4% |
| FY2013 | Dec 29, 2013 | $132.40M | +0.4% |
| FY2012 | Dec 30, 2012 | $131.84M | +13.8% |
| FY2011 | Jan 1, 2012 | $115.82M | +22.2% |
| FY2010 | Jan 2, 2011 | $94.81M | +4.8% |
| FY2009 | Jan 3, 2010 | $90.49M | -2.7% |
| FY2008 | Dec 28, 2008 | $93.03M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 5, 2026 | $48.97M | -8.1% |
| Q1 FY2026 | Apr 5, 2026 | $57.89M | +8.0% |
| Q4 FY2025 | Dec 28, 2025 | $58.18M | +18.2% |
| Q3 FY2025 | Sep 28, 2025 | $50.80M | +3.4% |
| Q2 FY2025 | Jun 29, 2025 | $53.27M | +10.7% |
| Q1 FY2025 | Mar 30, 2025 | $53.60M | +6.4% |
| Q4 FY2024 | Dec 29, 2024 | $49.21M | -0.8% |
| Q3 FY2024 | Sep 29, 2024 | $49.14M | -7.3% |
| Q2 FY2024 | Jun 30, 2024 | $48.13M | -15.9% |
| Q1 FY2024 | Mar 31, 2024 | $50.36M | -11.2% |
| Q4 FY2023 | Dec 31, 2023 | $49.60M | -9.1% |
| Q3 FY2023 | Oct 1, 2023 | $53.04M | -0.9% |
| Q2 FY2023 | Jul 2, 2023 | $57.25M | +2.2% |
| Q1 FY2023 | Apr 2, 2023 | $56.69M | -1.4% |
| Q4 FY2022 | Jan 1, 2023 | $54.54M | -10.0% |
| Q3 FY2022 | Oct 2, 2022 | $53.52M | +8.3% |
| Q2 FY2022 | Jul 3, 2022 | $56.04M | -14.9% |
| Q1 FY2022 | Apr 3, 2022 | $57.52M | -4.5% |
| Q4 FY2021 | Jan 2, 2022 | $60.58M | +6.6% |
| Q3 FY2021 | Oct 3, 2021 | $49.42M | -1.4% |
| Q2 FY2021 | Jul 4, 2021 | $65.82M | +32.9% |
| Q1 FY2021 | Apr 4, 2021 | $60.22M | +23.1% |
| Q4 FY2020 | Jan 3, 2021 | $56.82M | +19.3% |
| Q3 FY2020 | Oct 4, 2020 | $50.13M | +10.5% |
| Q2 FY2020 | Jul 5, 2020 | $49.52M | +2.4% |
| Q1 FY2020 | Apr 5, 2020 | $48.91M | +1.9% |
| Q4 FY2019 | Dec 29, 2019 | $47.64M | -8.3% |
| Q3 FY2019 | Sep 29, 2019 | $45.38M | -7.1% |
| Q2 FY2019 | Jun 30, 2019 | $48.34M | +2.4% |
| Q1 FY2019 | Mar 31, 2019 | $47.98M | +4.3% |
| Q4 FY2018 | Dec 30, 2018 | $51.97M | +37.7% |
| Q3 FY2018 | Sep 30, 2018 | $48.85M | +40.0% |
| Q2 FY2018 | Jul 1, 2018 | $47.20M | +40.6% |
| Q1 FY2018 | Apr 1, 2018 | $45.98M | +38.1% |
| Q4 FY2017 | Dec 31, 2017 | $37.73M | +14.9% |
| Q3 FY2017 | Oct 1, 2017 | $34.89M | +18.2% |
| Q2 FY2017 | Jul 2, 2017 | $33.56M | – |
| Q1 FY2017 | Apr 2, 2017 | $33.29M | – |
| Q4 FY2016 | Jan 1, 2017 | $32.83M | – |
| Q3 FY2016 | Oct 2, 2016 | $29.51M | – |
See a number that looks wrong?